HC Wainwright Reaffirms Buy on Jade Biosciences, $55 Target
HC Wainwright & Co. reiterated their Buy rating on Jade Biosciences's stock with a price target of $55.00, implying an upside of 291.5% from the Sep 30 close of $14.05.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.